Rapid and indirect inhibition of organic anion transporting polypeptide (OATP) 1B1 transport activity by lysosomotropic drug chloroquine: implications in OATP-mediated drug-drug interactions

被引:0
|
作者
Alam, Khondoker [1 ]
Abuznait, Alaa [1 ]
Pahwa, Sonia [1 ]
Wang, Xueying [2 ]
Zhang, Pengyue [2 ]
Ding, Kai [3 ]
Li, Lang [2 ]
Yue, Wei [1 ]
机构
[1] Univ Oklahoma, Hlth Sci Ctr, Coll Pharm, Pharmaceut Sci, Oklahoma City, OK 73190 USA
[2] Indiana Univ Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN 46202 USA
[3] Univ Oklahoma, Hlth Sci Ctr, Dept Biostat & Epidemiol, Oklahoma City, OK USA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
P268
引用
收藏
页码:152 / 152
页数:1
相关论文
共 50 条
  • [21] Characterization of simvastatin acid uptake by organic anion transporting polypeptide 3A1 (OATP3A1) and influence of drug-drug interaction
    Atilano-Roque, Amandla
    Joy, Melanie S.
    TOXICOLOGY IN VITRO, 2017, 45 : 158 - 165
  • [22] Role of OATP2B1 in Drug Absorption and Drug-Drug Interactions
    Chen, Mingqing
    Gibson, Alice
    Fu, Qiang
    Hu, Shuiying
    Sparreboom, Alex
    FASEB JOURNAL, 2019, 33
  • [23] Organic Anion Transporting Polypeptide (OATP)1B1 and OATP1B3 as Important Regulators of the Pharmacokinetics of Substrate Drugs
    Maeda, Kazuya
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2015, 38 (02) : 155 - 168
  • [24] Preclinical Mouse Models To Study Human OATP1B1-and OATP1B3-Mediated Drug-Drug Interactions in Vivo
    Durmus, Selvi
    Lozano-Mena, Gloria
    van Esch, Anita
    Wagenaar, Els
    van Tellingen, Olaf
    Schinkel, Alfred H.
    MOLECULAR PHARMACEUTICS, 2015, 12 (12) : 4259 - 4269
  • [25] Interindividual and interethnic variability in drug disposition: polymorphisms in organic anion transporting polypeptide 1B1 (OATP1B1; SLCO1B1)
    Lee, Hannah H.
    Ho, Richard H.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 83 (06) : 1176 - 1184
  • [26] STATISTICAL ANALYSIS TO COMPARE VARIOUS IN VITRO CRITERIA FOR PREDICTING ORGANIC ANION TRANSPORTING POLYPEPTIDES 1B1 (OATP1B1)-MEDIATED DRUG INTERACTIONS IN VIVO
    Arya, V.
    Vaidyanathan, J.
    Yoshida, K.
    Yang, X.
    Zhang, L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S21 - S22
  • [27] What kind of assumptions should we use to improve the predictability of drug-drug interactions involving organic anion transporting polypeptide (OATP) substrates?
    Maeda, Kazuya
    Yoshida, Kenta
    Sugiyama, Yuichi
    DRUG METABOLISM REVIEWS, 2011, 43 : 99 - 99
  • [28] Organic Anion-Transporting Polypeptide (OATP)-Mediated Drug-Drug Interaction Study between Rosuvastatin and Cyclosporine A in Chimeric Mice with Humanized Liver
    Uchida, Masashi
    Tajima, Yoriko
    Kakuni, Masakazu
    Kageyama, Yutaka
    Okada, Taro
    Sakurada, Eri
    Tateno, Chise
    Hayashi, Ryoji
    DRUG METABOLISM AND DISPOSITION, 2018, 46 (01) : 11 - 19
  • [29] Recent advances in preclinical in vitro approaches towards quantitative prediction of hepatic clearance and drug-drug interactions involving organic anion transporting polypeptide (OATP) 1B transporters
    Nozaki, Yoshitane
    Izumi, Saki
    DRUG METABOLISM AND PHARMACOKINETICS, 2020, 35 (01) : 56 - 70
  • [30] Relative Activity Factor (RAF)-Based Scaling of Uptake Clearance Mediated by Organic Anion Transporting Polypeptide (OATP) 1B1 and OATP1B3 in Human Hepatocytes
    Izumi, Saki
    Nozaki, Yoshitane
    Kusuhara, Hiroyuki
    Hotta, Koichiro
    Mochizuki, Toshiki
    Komori, Takafumi
    Maeda, Kazuya
    Sugiyama, Yuichi
    MOLECULAR PHARMACEUTICS, 2018, 15 (06) : 2277 - 2288